For a better experience of our website please update you web browser from IE11 to Microsoft Edge or an alternative modern browser such as Google Chrome. Thank you.

Escientia Life Sciences website logo

Scientific and Commercial Leadership Strengths

Escientia’s leadership team brings the mindset and quality orientation from source of the largest and most successful pharmaceutical campanies in the world.

Yadagiri Pendri, PHD, CEO & MD

>35 years experience

Former pharmaceutical executive with a track record in the development, technology transfer and commercialisation of several New Chemical Entities (NCE) across the globe

Held leadership roles at Process Research & Development, Bristol-Myers Squibb, USA in the development of small molecules and antibody drug conjugates (ADCs)

Technological expertise and know-how to manufacture architecturally complex intermediates and APIs by utilising state-of-the-art synthetic organic chemistry and cutting-edge technology platforms.

At Escientia, collaborated with several innovator biotech and pharmaceutical companies for successful discovery, development and commercialisation of advanced intermediates and novel APIs

Co-inventor of 15 US patents and 40 publications. Recipient of 4 Bristol-Myers Squibb Pharmaceutical Research Institute Presidents Awards.

Marcel Velterop – Co-CEO

>30 years Experience

Over 20 Years in Pharma of which 17 in the CDMO industry

Variety of global leadership roles at DSM, Dr Reddy’s, Sai Life Sciences & Jubilant Biosys.

Extensive experience in working with India and global innovators.
Worked directly on development, commercial API’s and NCE’s with 7 of the top 12 innovators.

Led logistics & commercial teams, as well as UK Based API plant and R&D centre in Cambridge, UK.

Kiran Pendri – President

>10 years experience

Experience collaborating with global pharma and biotech innovators.

Partnering with clients on all stages of clinical and commercial projects.

Commercial and operations at Escientia since its founding.